Terumo (OTCMKTS:TRUMY) Stock Price Up 5.1% – Should You Buy?

Terumo Corp. (OTCMKTS:TRUMY) traded up 5.1% during trading on Friday . The stock traded as high as $12.93 and last traded at $12.80. 89,837 shares were traded during trading, a decline of 76% from the average session volume of 377,455 shares. The stock had previously closed at $12.18.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the stock. Zacks Research upgraded shares of Terumo to a “hold” rating in a report on Thursday, April 9th. Nomura upgraded shares of Terumo to a “hold” rating in a report on Tuesday, February 24th. Two research analysts have rated the stock with a Hold rating, According to MarketBeat, Terumo has an average rating of “Hold”.

Terumo Price Performance

The stock’s fifty day moving average price is $13.08 and its two-hundred day moving average price is $14.01. The firm has a market capitalization of $18.82 billion, a price-to-earnings ratio of 22.00 and a beta of 0.62. The company has a current ratio of 1.51, a quick ratio of 0.89 and a debt-to-equity ratio of 0.07.

Terumo (OTCMKTS:TRUMY) last announced its quarterly earnings data on Friday, May 15th. The company reported $0.11 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.11. Terumo had a net margin of 11.74% and a return on equity of 9.01%. Equities research analysts expect that Terumo Corp. will post 0.58 EPS for the current year.

About Terumo

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.